The MLL recombinome of acute leukemias in 2013

Claus Meyer, Jörg Hofmann, Thomas Burmeister, +82

Leukemia

Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure

Mohammed Wattad, Daniela Weber, Konstanze Döhner, +22

Leukemia

Hematological MalignancyBone Marrow FailureInduction FailureMedicineAcute Myeloid Leukemia +9

Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML–BFM and DCOG study groups

Frédérik Damm, Felicitas Thol, Iris H.I.M. Hollink, +12

Leukemia

Genetic DisorderGeneticsInherited Metabolic DiseaseGenetic EpidemiologyPediatrics +7

siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts

Jenny Dunne, Markus Ritter, N Martinez Soria, +9

Oncogene

Primary Aml BlastsCell RegulationMedicineImmunologyProliferation-associated Gene Expression +4

Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia

D. Messerer, Jutta Engel, Joerg Hasford, +12

Haematologica

Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia

MP Wattjes, J Krauter, Stefan Nagel, +3

Leukemia

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaHematologyImmunology +8

Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial

Meinolf Karthaus, C. Julian Rosenthal, G. Huebner, +7

Bone Marrow Transplantation

InflammationAllergyOral CavityImmunologyOral Hygiene +6

Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia

Sonia Jaramillo, Axel Benner, J Krauter, +30

Blood Cancer Journal

Risk-adapted induction and consolidation therapy in adults with de novo AML aged =�60�years: results of a prospective multicenter trial

Gerhard Heil, J Krauter, A. Raghavachar, +9

Annals of Hematology

OncologyProspective Multicenter TrialDisease ProgressionRisk-adapted InductionConsolidation Therapy +3

FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype

Katharina Wagner, Frédérik Damm, Felicitas Thol, +8

Haematologica